An Evaluation Of The Fitting Success Rate Of Senofilcon A Soft Contact Lenses In Three Designs.
NCT ID: NCT03384628
Last Updated: 2018-06-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
51 participants
INTERVENTIONAL
2018-01-26
2018-05-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Clinical Comparison of Senofilcon A and Stenfilcon A Contact Lenses
NCT02643004
Comparison of a Daily Disposable Multifocal Contact Lens to a Marketed Product
NCT05101252
Comparison of Senofilcon A Toric Lenses to Balafilcon A Toric Lenses Over Extended Wear Period
NCT00762502
Evaluation of Investigational Daily Disposable Multifocal Contact Lenses Produced With Different Manufacturing Processes in Myopes
NCT04889625
Clinical Performance Comparison of Several Different Contact Lenses
NCT00912028
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
First Pair Senofilcon A contact lens
The first pair of Senofilcon A contact lenses is applied (according to the fitting schedule), allowed to settle before assessment of the first pair Senofilcon A contact lens and subsequent removal.
First pair Senofilcon A contact lens
Fit assessment of the first pair contact lenses.
Second pair Senofilcon A contact lens
The second pair of contact lenses is applied (according to the fitting schedule), allowed to settle before assessment of the second pair Senofilcon A contact lens and subsequent removal.
Second pair Senofilcon A contact lens
Fit assessment of the second pair of contact lenses.
Third pair Senofilcon A contact lens
The third pair of Senofilcon A contact lens is applied (according to the fitting schedule), allowed to settle before assessment of the third pair Senofilcon A contact lens and subsequent removal.
Third pair Senofilcon A contact lens
Fit assessment of the third pair of contact lenses.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
First pair Senofilcon A contact lens
Fit assessment of the first pair contact lenses.
Second pair Senofilcon A contact lens
Fit assessment of the second pair of contact lenses.
Third pair Senofilcon A contact lens
Fit assessment of the third pair of contact lenses.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to read, comprehend and sign an informed consent.
* Willing to comply with the wear and study assessment schedule.
* Spherical distance prescription between -0.50 and -6.00 (inc.).
* Astigmatism, if present,≤1.50DC in both eyes.
* Have normal eyes with no evidence of any ocular abnormality or disease. For the purposes of this study a normal eye is defined as one having:
A clear central cornea. No anterior segment disorders. No clinically significant slit lamp findings (i.e. corneal oedema, significant staining, central scarring, infiltrates, active neovascularisation). No other active ocular disease (including pterygia).
Exclusion Criteria
* Any active corneal infection, injury or inflammation
. •Large pinguecula likely to affect soft lens fit
* Systemic or ocular disease or medication which might interfere with CL wear
* Pregnancy or breastfeeding
* Participation in any concurrent trial
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Visioncare Research Ltd.
OTHER
Graeme Young
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Graeme Young
Graeme Young PhD MPhil FCOptom DCLP
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Graeme Young, PhD MPhil
Role: STUDY_DIRECTOR
Managing director
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Visioncare research
Farnham, Surrey, United Kingdom
Aston University Optometry Clinic
Birmingham, West Midlands, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Informed Consent Form
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TRTN-501
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.